<DOC>
	<DOCNO>NCT00670215</DOCNO>
	<brief_summary>The primary purpose clinical trial compare double-blind randomized trial , efficacy safety ciprofloxacin MR 1000 mg tablet give single-dose multiple-dose regimen prevention infectious complication patient undergo transrectal needle biopsy prostate ( TRNBP ) .</brief_summary>
	<brief_title>BAYQ3939 , 1000 mg Tablet Transrectal Needle Biopsies Prostate ( TRNBP ) - Infection Prophylaxis</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Transrectal needle biopsy prostate require . A cleancatch midstreamurine ( MSU ) culture negative ( &lt; 104 CFU/mL ) possible pathogen PreTherapy Visit prior TRNBP . Gastrointestinal absorption adequate evidence passage gas feces per rectum patient tolerate oral food , fluid , medication without vomit diarrhea . History hypersensitivity ciprofloxacin quinolone antibiotic Valvular heart disease require antibiotic prophylaxis prevent bacterial endocarditis Concomitant use theophylline , probenecid , warfarin time entire study Renal insufficiency Known suspect central nervous system disorder may predispose seizure low seizure threshold Absolute neutrophil count ( ANC ) &lt; 1000/mm3 Human immunodeficiency virus ( HIV ) infection CD4 count &lt; 200 cells/micL . HIV test NOT require Antibiotic administration within one week TRNBP Severe hepatic insufficiency ( ChildPugh C )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Prevention infectious complication</keyword>
	<keyword>transrectal needle biopsy prostate</keyword>
	<keyword>TRNBP</keyword>
</DOC>